rs182816010
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_001039141.3(TRIOBP):c.4103G>A(p.Arg1368Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000936 in 1,613,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIOBP | NM_001039141.3 | c.4103G>A | p.Arg1368Gln | missense_variant | 9/24 | ENST00000644935.1 | NP_001034230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.4103G>A | p.Arg1368Gln | missense_variant | 9/24 | NM_001039141.3 | ENSP00000496394 | A2 | ||
TRIOBP | ENST00000344404.10 | c.*3586G>A | 3_prime_UTR_variant, NMD_transcript_variant | 7/22 | 2 | ENSP00000340312 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000158 AC: 39AN: 247292Hom.: 1 AF XY: 0.000104 AC XY: 14AN XY: 134720
GnomAD4 exome AF: 0.0000637 AC: 93AN: 1460984Hom.: 0 Cov.: 57 AF XY: 0.0000550 AC XY: 40AN XY: 726776
GnomAD4 genome AF: 0.000381 AC: 58AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 27AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 17, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | TRIOBP: BP4 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 21, 2016 | p.Arg1368Gln in exon 9 of TRIOBP: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. Of note, >5 mammals have a glutamine (Gln) at this position despite high nearby am ino acid conservation. In addition, computational prediction tools do not sugges t a high likelihood of impact to the protein. It has been identified in 0.1% (9/ 9264) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://e xac.broadinstitute.org; dbSNP rs182816010). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at